Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
International exercise recommendations in older adults (ICFSR): Expert consensus guidelines
Izquierdo, M., Merchant, R. A., Morley, J. E., Anker, S. D., Aprahamian, I., Arai, H., Aubertin-Leheudre, M., Bernabei, R., Cadore, E. L., Cesari, M., et al. (2021) · The Journal of nutrition, health and aging · doi:10.1007/s12603-021-1665-8 · Cited by 1,247
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“Skeletal muscle is the principal organ for insulin-stimulated glucose uptake (i.e., capable for 80% of glucose disposal in human), and muscle IR plays a key part in T2D etiology (DeFronzo and Tripathy, 2009; Honka et al., 2018).”
BackgroundThe integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Insulin Resistance: From Mechanisms to Therapeutic Strategies
Lee, S.-H., Park, S.-Y., & Choi, C. S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0280 · Cited by 1,092
“Insulin resistance in skeletal muscle Insulin-stimulated glucose consumption is largely conducted in skeletal muscle, and thus, muscular insulin resistance could affect whole-body metabolism [28].”
BackgroundCopps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017
“Prospective studies first identify insulin resistance in human skeletal muscle, which is thought to contribute, via a dys-metabolic process, to the emergence of phenotypic disease [3, 74].”
BackgroundMetabolic Flexibility in Health and Disease
Goodpaster, B. H., & Sparks, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.015 · Cited by 995
“, 2012), and an enormous body of work supports a causal role for skeletal muscle insulin resistance in type 2 diabetes (DeFronzo and Tripathy, 2009; Petersen et al., 2007).”
Autophagy—a key player in cellular and body metabolism
Kim, K. H., & Lee, M.-S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.35 · Cited by 963
Molecular mechanisms of ROS production and oxidative stress in diabetes
Newsholme, P., Cruzat, V. F., Keane, K. N., Carlessi, R., & de Bittencourt, P. I. H. (2016) · Biochemical Journal · doi:10.1042/bcj20160503c · Cited by 878
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
Regulation of glucose homeostasis by glucocorticoids
Kuo, T., McQueen, A., Chen, T.-C., & Wang, J.-C. (2015) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-2895-8_5 · Cited by 723
Neinast, M., Murashige, D., & Arany, Z. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114455 · Cited by 714
Skeletal muscle inflammation and insulin resistance in obesity
Wu, H., & Ballantyne, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88880 · Cited by 695
The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity
González Hernández, M. A., Canfora, E. E., Jocken, J. W. E., & Blaak, E. E. (2019) · Nutrients · doi:10.3390/nu11081943 · Cited by 624
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
McArdle, M. A., Finucane, O. M., Connaughton, R. M., McMorrow, A. M., & Roche, H. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00052 · Cited by 532
“Skeletal muscle is the main target organ for glucose uptake in the body, responsible for 80% of glucose disposal in man (Lorenzo et al., 2008; DeFronzo and Tripathy, 2009).”
BackgroundThe Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
“Development of β-cells lipotoxicity in non-diabetic subjects, but genetically predisposed to develop T2DM, was associated with impaired insulin release and secretion [72] (Figure 6).”
BackgroundInfluentialSex Differences in Body Composition
Bredella, M. A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_2 · Cited by 523
“Impaired insulin action at the level of skeletal muscle is central to the clinical manifestations of insulin resistance and T2DM (DeFronzo and Tripathy 2009).”
BackgroundRole of Skeletal Muscle in Insulin Resistance and Glucose Uptake
Merz, K. E., & Thurmond, D. C. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190029 · Cited by 494
“DOC2B is a potential therapeutic candidate in T2D because of its ability to promote and protect functional beta-cell mass and to enhance and protect glucose homeostasis in vivo .”
InfluentialExercise-stimulated glucose uptake — regulation and implications for glycaemic control
Sylow, L., Kleinert, M., Richter, E. A., & Jensen, T. E. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.162 · Cited by 498
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484
Jing, E., Emanuelli, B., Hirschey, M. D., Boucher, J., Lee, K. Y., Lombard, D., Verdin, E. M., & Kahn, C. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111308108 · Cited by 469
Lee, M.-S., Hsu, C.-C., Wahlqvist, M. L., Tsai, H.-N., Chang, Y.-H., & Huang, Y.-C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-20 · Cited by 380
“There are gender differences in the development of body fat distribution with relatively earlier and greater abdominal fatness (and fatty liver) in men [28] and in the protective role of estrogen against insulin resistance [29-33].”
BackgroundRole of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
“Humans with congenital generalized lipodystrophy develop extreme insulin resistance and its complications, such as T2DM, hyperlipidemia, and fatty liver [66].”
BackgroundInfluentialReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Sex differences in body composition and association with cardiometabolic risk
Schorr, M., Dichtel, L. E., Gerweck, A. V., Valera, R. D., Torriani, M., Miller, K. K., & Bredella, M. A. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0189-3 · Cited by 392
“Skeletal muscle plays an important role in the regulation of glucose homeostasis [32], and low muscle mass contributes to increased risk of T2DM [33, 34].”
BackgroundChanges in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies
Neeland, I. J., Linge, J., & Birkenfeld, A. L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15728 · Cited by 391
“8,9 Studies indicate that weight gain and loss correlate with decreasing and increasing insulin sensitivity, respectively.”
Hong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
Tissue–Specific Insulin Signaling, Metabolic Syndrome, and Cardiovascular Disease
Rask-Madsen, C., & Kahn, C. R. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241919 · Cited by 375
“up by skeletal muscle and used for glycogen synthesis and glycolysis.(11) In insulin resistance, insulin signaling through IRS-”
BackgroundMethodInfluentialThe many actions of insulin in skeletal muscle, the paramount tissue determining glycemia
Sylow, L., Tokarz, V. L., Richter, E. A., & Klip, A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.020 · Cited by 366
Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?
Malone, J. I., & Hansen, B. C. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12787 · Cited by 354
“Several studies have found that members of the groups named above have high levels of insulin circulating before they become fat and that insulin resistance was found to be isolated in the muscle mass.(32) The individuals who have increased resistance to the action of insulin in their muscles always have higher circul…”
BackgroundExercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle
Stanford, K. I., & Goodyear, L. J. (2014) · Advances in Physiology Education · doi:10.1152/advan.00080.2014 · Cited by 348
“This increase in circulating insulin can result in impaired glucose transport into liver, skeletal muscle, and adipose tissue (11).”
BackgroundObesity and cardiovascular disease: An ESC clinical consensus statement
Koskinas, K. C., Van Craenenbroeck, E. M., Antoniades, C., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae508 · Cited by 313
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 308
“Skeletal muscle insulin resistance largely contributes to whole body glucose levels and the presence of a pro-inflammatory environment, as the body is comprised of 40–50%muscle by weight (DeFronzo and Tripathy, 2009; Weiss et al., 2013).”
BackgroundCentral role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders
Song, R., Peng, W., Zhang, Y., Lv, F., Wu, H.-K., Guo, J., Cao, Y., Pi, Y., Zhang, X., Jin, L., et al. (2013) · Nature · doi:10.1038/nature11834 · Cited by 303
Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes
Zhao, N., Liu, C.-C., Van Ingelgom, A. J., Martens, Y. A., Linares, C., Knight, J. A., Painter, M. M., Sullivan, P. M., & Bu, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.003 · Cited by 289
Adipo-myokines: two sides of the same coin–mediators of inflammation and mediators of exercise
Raschke, S., & Eckel, J. (2013) · Mediators of Inflammation · doi:10.1155/2013/320724 · Cited by 296
“The activation of inflammatory pathways leads to insulin resistance in peripheral tissues such as skeletal muscle and adipose tissue itself, constituting an early defect in the pathogenesis of type 2 diabetes [15].”
BackgroundBuford, T. W., Anton, S. D., Judge, A. R., Marzetti, E., Wohlgemuth, S. E., Carter, C. S., Leeuwenburgh, C., Pahor, M., & Manini, T. M. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.004 · Cited by 295
“Along with the well-characterized effects of insulin resistance on muscle (DeFronzo and Tripathy, 2009), sarcopenia and type 2 DM share a common set of lifestyle factors, including physical inactivity and a poor diet that contribute to accelerated muscle atrophy.”
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
Khodabandehloo, H., Gorgani-Firuzjaee, S., Panahi, G., & Meshkani, R. (2016) · Translational Research · doi:10.1016/j.trsl.2015.08.011 · Cited by 295
Metcalfe, R. S., Babraj, J. A., Fawkner, S. G., & Vollaard, N. B. J. (2012) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2254-z · Cited by 294
“The primary defect underlying the development of T2D is skeletal muscle insulin resistance (DeFronzo and Tripathy 2009).”
BackgroundAMPK and Exercise: Glucose Uptake and Insulin Sensitivity
O'Neill, H. M. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.1 · Cited by 295
“Skeletal muscle is responsible for around 80% of insulin-stimulated glucose disposal [23-25]; therefore, responsiveness to insulin in this tissue is important for regulating whole-body insulin sensitivity.”
BackgroundSultana, R. N., Sabag, A., Keating, S. E., & Johnson, N. A. (2019) · Sports Medicine · doi:10.1007/s40279-019-01167-w · Cited by 286
Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation
Jing, E., O’Neill, B. T., Rardin, M. J., Kleinridders, A., Ilkeyeva, O. R., Ussar, S., Bain, J. R., Lee, K. Y., Verdin, E. M., Newgard, C. B., et al. (2013) · Diabetes · doi:10.2337/db12-1650 · Cited by 283
“In both insulin resistance and type 2 diabetes, this metabolic flexibility is compromised in that skeletal muscle fails to switch substrate utilization from lipid metabolism to insulin-stimulated glucose oxidation (5,48).”
BackgroundAssessment of Insulin Secretion and Insulin Resistance in Human
Park, S. Y., Gautier, J.-F., & Chon, S. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0220 · Cited by 281
Reduced physical activity in young and older adults: Metabolic and musculoskeletal implications
Bowden Davies, K. A., Pickles, S., Sprung, V. S., Kemp, G. J., Alam, U., Moore, D. R., Tahrani, A. A., & Cuthbertson, D. J. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819888824 · Cited by 278
Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier
Vacanti, N. M., Divakaruni, A. S., Green, C. R., Parker, S. J., Henry, R. R., Ciaraldi, T. P., Murphy, A. N., & Metallo, C. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.024 · Cited by 277
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurode-”
BackgroundIzquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
Takiishi, T., Gysemans, C., Bouillon, R., & Mathieu, C. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.02.013 · Cited by 270
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Macrophages, Chronic Inflammation, and Insulin Resistance
Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., & Zheng, W. (2022) · Cells · doi:10.3390/cells11193001 · Cited by 264
Resistance Exercise Training as a Primary Countermeasure to Age-Related Chronic Disease
Mcleod, J. C., Stokes, T., & Phillips, S. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00645 · Cited by 254
Yan, J., Wang, C., Jin, Y., Meng, Q., Liu, Q., Liu, Z., Liu, K., & Sun, H. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.026 · Cited by 248
Ferreira, N. N., Ferreira, L. M. B., Cardoso, V. M. O., Boni, F. I., Souza, A. L. R., & Gremião, M. P. D. (2018) · European Polymer Journal · doi:10.1016/j.eurpolymj.2017.12.004 · Cited by 245
“Type 2 diabetes generally occurs in middle-aged people, and insulin resistance is its main defect, which is characterized by low responses of target tissues to insulin [208,211,212].”
BackgroundMetabolic functions of glucocorticoid receptor in skeletal muscle
Kuo, T., Harris, C. A., & Wang, J.-C. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.003 · Cited by 241
“Approximately 80% of glucose utiliza- tion occurs in skeletal muscle (DeFronzo and Tripathy, 2009; Ferrannini et al., 1988).”
BackgroundPatel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., Dias, D. D. S., Gupta, S., & Singal, P. K. (2016) · Heart Failure Reviews · doi:10.1007/s10741-015-9515-6 · Cited by 240
“which leads to inefficiency or failure of insulin action that leads to systemic insulin resistance condition [26, 27] as shown in Fig.”
BackgroundExosomes as new players in metabolic organ cross‐talk
Guay, C., & Regazzi, R. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13027 · Cited by 241
“over, the insulin-resistant state of skeletal muscles is considered the primary defect leading to type 2 diabetes development.(64) Mus-”
BackgroundMechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Silva Rosa, S. C., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 240
“Akt2 is required for hepatic lipid accumulation in models of insulin resistance.”
BackgroundInfluentialLepretti, M., Martucciello, S., Burgos Aceves, M., Putti, R., & Lionetti, L. (2018) · Nutrients · doi:10.3390/nu10030350 · Cited by 232
“Skeletal muscle seems to play a significant role in whole body insulin resistance [2,3].”
Backgroundl-Citrulline Supplementation: Impact on Cardiometabolic Health
Allerton, T., Proctor, D., Stephens, J., Dugas, T., Spielmann, G., & Irving, B. (2018) · Nutrients · doi:10.3390/nu10070921 · Cited by 231
Sargeant, J. A., Henson, J., King, J. A., Yates, T., Khunti, K., & Davies, M. J. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.3.247 · Cited by 231
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
Marjot, T., Moolla, A., Cobbold, J. F., Hodson, L., & Tomlinson, J. W. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz009 · Cited by 228
Fatty Acids and NLRP3 Inflammasome–Mediated Inflammation in Metabolic Tissues
Ralston, J. C., Lyons, C. L., Kennedy, E. B., Kirwan, A. M., & Roche, H. M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064836 · Cited by 225
Ursolic acid in health and disease
Seo, D. Y., Lee, S. R., Heo, J.-W., No, M.-H., Rhee, B. D., Ko, K. S., Kwak, H.-B., & Han, J. (2018) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2018.22.3.235 · Cited by 225
“They are major regulator energy catabolism and postprandial glucose disposal [72,73], and are essential for whole body metabolism and locomotion [74,75].”
BackgroundMetabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic links
Zafar, U., Khaliq, S., Ahmad, H. U., Manzoor, S., & Lone, K. P. (2018) · Hormones · doi:10.1007/s42000-018-0051-3 · Cited by 221
Choi, Y., Kwon, Y., Kim, D.-K., Jeon, J., Jang, S. C., Wang, T., Ban, M., Kim, M.-H., Jeon, S. G., Kim, M.-S., et al. (2015) · Scientific Reports · doi:10.1038/srep15878 · Cited by 218
The Key Role of Mitochondrial Function in Health and Disease
San-Millán, I. (2023) · Antioxidants · doi:10.3390/antiox12040782 · Cited by 218
“Since skeletal muscle seems to be the tissue with the highest uptake of glucose, DeFronzo and Tipathy as well as Fernendez and colleagues proposed that T2D debuts in skeletal muscle and that muscle insulin resistance is the primary mechanistic event involved in the development of T2D [169,170].”
BackgroundTargeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
Yang, H., & Yang, L. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0316 · Cited by 203
Kolczynska, K., Loza-Valdes, A., Hawro, I., & Sumara, G. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01286-8 · Cited by 199
Kim, G., Lee, S., Lee, Y., Jun, J. E., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Hepatology · doi:10.1002/hep.30049 · Cited by 198
“1756 utilization and secretion of myokines that mediate crosstalk among muscle, liver, adipose tissue, and other organs.(6,7) Several studies have reported that low muscle mass is associated with the prevalence of NAFLD in cross-sectional settings,(8-11) but longitudinal data exploring the causal relationship between…”
BackgroundYip, W., Sequeira, I., Plank, L., & Poppitt, S. (2017) · Nutrients · doi:10.3390/nu9111273 · Cited by 177
Massart, J., Sjögren, R. J. O., Lundell, L. S., Mudry, J. M., Franck, N., O’Gorman, D. J., Egan, B., Zierath, J. R., & Krook, A. (2017) · Diabetes · doi:10.2337/db17-0141 · Cited by 196
“Skeletal muscle is a major site of glucose disposal, and in patients with type 2 diabetes it is characterized by diminished insulin-mediated glucose transport and metabolism (21).”
BackgroundRudrappa, S. S., Wilkinson, D. J., Greenhaff, P. L., Smith, K., Idris, I., & Atherton, P. J. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00361 · Cited by 192
Muscle and adipose tissue insulin resistance: malady without mechanism?
Fazakerley, D. J., Krycer, J. R., Kearney, A. L., Hocking, S. L., & James, D. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r087510 · Cited by 185
“3 majority of glucose from a meal is deposited in muscle and liver with as little as 5% taken up by adipose tissue (13-15).”
BackgroundAswad, H., Forterre, A., Wiklander, O. P. B., Vial, G., Danty-Berger, E., Jalabert, A., Lamazière, A., Meugnier, E., Pesenti, S., Ott, C., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3337-2 · Cited by 185
“Although communication between SkM and other tissues appears to be important in the relationship between obesity and diabetes [12], the possibility that SkM-derived exosomes act as a mode of systemic communication has hitherto never been discussed.”
BackgroundPark, S., Jeon, J.-H., Min, B.-K., Ha, C.-M., Thoudam, T., Park, B.-Y., & Lee, I.-K. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0101 · Cited by 184
“In response to starvation, adenosine monophosphate (AMP)-activated protein kinase (AMPK) initiates the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) signaling pathway, which is responsible for the rapid structural and metabolic adaptation from glucose to fatty acids [32,33].”
Notch signaling as a novel regulator of metabolism
Bi, P., & Kuang, S. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.02.006 · Cited by 183
Linge, J., Birkenfeld, A. L., & Neeland, I. J. (2024) · Circulation · doi:10.1161/circulationaha.124.067676 · Cited by 180
“6,7 Studies indicate that weight gain and loss correlate with decreasing and increasing insulin sensitivity, respectively.”
Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains
Culley, M. K., & Chan, S. Y. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120847 · Cited by 180
Khan, I. M., Perrard, X.-Y., Brunner, G., Lui, H., Sparks, L. M., Smith, S. R., Wang, X., Shi, Z.-Z., Lewis, D. E., Wu, H., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.104 · Cited by 178
“22,23 29 Research has also shown existence of extramyocellular adipose tissue (EMAT) compartments.”
McCrimmon, R. J., Catarig, A.-M., Frias, J. P., Lausvig, N. L., le Roux, C. W., Thielke, D., & Lingvay, I. (2020) · Diabetologia · doi:10.1007/s00125-019-05065-8 · Cited by 184
Jalabert, A., Vial, G., Guay, C., Wiklander, O. P. B., Nordin, J. Z., Aswad, H., Forterre, A., Meugnier, E., Pesenti, S., Regazzi, R., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3882-y · Cited by 177
“Until now, the relationship between insulin resistance in SkM and decrease of insulin secretion by the pancreas remains an enigma [28].”
BackgroundJung, J. Y., Lim, Y., Moon, M. S., Kim, J. Y., & Kwon, O. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-18 · Cited by 175
“The effect of OPE on the plasma concentration of FFAs, the biomarkers of oxidative stress and inflammation in liver, the insulin receptor (INSR) and glucose transporter type 4 (GLUT4) expressions in skeletal muscle were also investigated.”
BackgroundInfluentialPathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity
Bansal, S. K., & Bansal, M. B. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17930 · Cited by 178
“57 Continuous exposure to high insulin has been shown to promote both serine/threonine phosphorylation, thereby decreasing IRS1 and GLUT4 translocation to the plasma membrane, both of which promote insulin resistance in skeletal muscle.”
BackgroundThe multifaceted pyruvate metabolism: role of the mitochondrial pyruvate carrier
Zangari, J., Petrelli, F., Maillot, B., & Martinou, J.-C. (2020) · Biomolecules · doi:10.3390/biom10071068 · Cited by 172
Henagan, T. M., Stefanska, B., Fang, Z., Navard, A. M., Ye, J., Lenard, N. R., & Devarshi, P. P. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13058 · Cited by 171
“These diet-induced mitochondrial adaptations in muscle play a primary role in the development of whole body insulin resistance (IR) (Eriksson et al., 1989; DeFronzo and Tripathy, 2009) and might be linked to alterations in the epigenome, including changes in DNA methylation patterns and covalent histone modifications…”
BackgroundInfluentialNon-alcoholic fatty liver disease: A sign of systemic disease
Reccia, I., Kumar, J., Akladios, C., Virdis, F., Pai, M., Habib, N., & Spalding, D. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.011 · Cited by 169
The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis
Jaiswal, N., Gavin, M. G., Quinn, W. J., Luongo, T. S., Gelfer, R. G., Baur, J. A., & Titchenell, P. M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.001 · Cited by 167
Dhanya, R., Arya, A. D., Nisha, P., & Jayamurthy, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00336 · Cited by 167
“Also, insulin resistance associated with type 2 diabetes is mostly seen in skeletal muscle as it is the primary site of glucose as well as fatty acid utilization (DeFronzo and Tripathy, 2009).”
BackgroundMechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
Maintained exercise‐enhanced brain executive function related to cerebral lactate metabolism in men
Hashimoto, T., Tsukamoto, H., Takenaka, S., Olesen, N. D., Petersen, L. G., Sørensen, H., Nielsen, H. B., Secher, N. H., & Ogoh, S. (2018) · The FASEB Journal · doi:10.1096/fj.201700381rr · Cited by 156
“For example, patients with type 2 diabetes present impaired glycemic control mainly because of dysfunction of the skeletal-muscle metabolism (57), which may result in cognitive impairment (49, 58).”
BackgroundGenetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels
Mahendran, Y., Jonsson, A. E., Have, C. T., Allin, K. H., Witte, D. R., Jørgensen, M. E., Grarup, N., Pedersen, O. B., Kilpeläinen, T. O., & Hansen, T. F. (2017) · Diabetologia · doi:10.1007/s00125-017-4222-6 · Cited by 165
Pillon, N. J., Croze, M. L., Vella, R. E., Soulère, L., Lagarde, M., & Soulage, C. O. (2012) · Endocrinology · doi:10.1210/en.2011-1957 · Cited by 153
Dyar, K. A., Hubert, M. J., Mir, A. A., Ciciliot, S., Lutter, D., Greulich, F., Quagliarini, F., Kleinert, M., Fischer, K., Eichmann, T. O., et al. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2005886 · Cited by 153
Lankatillake, C., Huynh, T. T., & Dias, D. A. (2019) · Plant Methods · doi:10.1186/s13007-019-0487-8 · Cited by 187
Exercise and regulation of carbohydrate metabolism
Mul, J. D., Stanford, K. I., Hirshman, M. F., & Goodyear, L. J. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.020 · Cited by 151
“The hyperinsulinemic state can result in impaired glucose transport into the liver, skeletal muscle, and adipose tissue.(115) While type 2 diabetes is usually adult-onset, the number of children and adolescents afflicted by this disease is dramatically increasing.”
Elevated Muscle TLR4 Expression and Metabolic Endotoxemia in Human Aging
Ghosh, S., Lertwattanarak, R., Garduno, J. D. J., Galeana, J. J., Li, J., Zamarripa, F., Lancaster, J. L., Mohan, S., Hussey, S., & Musi, N. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu067 · Cited by 150
“Serine phosphorylation on IRS1 impairs its phosphorylation on tyrosine residues and downstream activation of Akt (63,64).”
BackgroundInfluentialKang, G. G., Francis, N., Hill, R. A., Waters, D. L., BLANCHARD, C. L., & Santhakumar, A. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010140 · Cited by 171
Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
DeFronzo, R. A., & Abdul-Ghani, M. (2011) · Diabetes Care · doi:10.2337/dc11-s221 · Cited by 147
“, insulin resistance or b-cell dysfunction, represents the primary abnormality (11,22) (74a–78a).”
BackgroundSelf-citation
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.